Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
FURX [NASD]
Furiex Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.49 Insider Own28.66% Shs Outstand10.11M Perf Week11.08%
Market Cap399.24M Forward P/E71.80 EPS next Y0.55 Insider Trans0.03% Shs Float7.25M Perf Month16.32%
Income-24.14M PEG- EPS next Q-1.28 Inst Own56.34% Short Float6.27% Perf Quarter6.76%
Sales77.19M P/S5.17 EPS this Y13.36% Inst Trans6.95% Short Ratio5.67 Perf Half Y115.09%
Book/sh4.96 P/B7.96 EPS next Y135.70% ROA-25.09% Target Price52.00 Perf Year150.57%
Cash/sh3.60 P/C10.96 EPS next 5Y- ROE-41.48% 52W Range16.92 - 42.30 Perf YTD105.04%
Dividend- P/FCF- EPS past 5Y0.00% ROI-30.90% 52W High-6.00% Beta-
Dividend %- Quick Ratio- Sales past 5Y135.43% Gross Margin- 52W Low134.99% ATR1.29
Employees24 Current Ratio1.94 Sales Q/Q1386.77% Oper. Margin-26.95% RSI (14)71.96 Volatility4.68% 3.39%
OptionableYes Debt/Eq0.80 EPS Q/Q184.07% Profit Margin-31.28% Rel Volume0.40 Prev Close39.49
ShortableYes LT Debt/Eq0.62 EarningsMay 07 AMC Payout- Avg Volume80.11K Price39.76
Recom1.30 SMA2014.96% SMA5012.05% SMA20053.39% Volume21,697 Change0.68%
28-Jan-13Reiterated Ladenburg Thalmann Buy $33 → $38
28-Jan-13Initiated Canaccord Genuity Buy $45
14-May-12Reiterated Ladenburg Thalmann Buy $28 → $33
02-Mar-12Initiated Ladenburg Thalmann Buy $30
21-Oct-11Initiated Global Hunter Securities Buy $18
17-May-13 01:04PM  FURIEX PHARMACEUTICALS, INC. Financials EDGAR Online Financials
12-May-13 02:58PM  5 Healthcare Stock Earnings Snapshots at Wall St. Cheat Sheet
09-May-13 12:35PM  Narrower-than-Expected Loss at ArQule Zacks
09:27AM  FURIEX PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
08-May-13 10:30PM  Furiex Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
07-May-13 05:46PM  Furiex Pharmaceuticals Earnings: Heres Why Investors are Not Happy Now at Wall St. Cheat Sheet
04:05PM  Furiex Reports First Quarter 2013 Financial Results Business Wire
11:13AM  Furiex Pharmaceuticals: Heres What Investors Need to Know Before Earnings at Wall St. Cheat Sheet
09:50AM  FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
07:07AM  Q1 2013 Furiex Pharmaceuticals Inc Earnings Release - After Market Close CCBN
06-May-13 12:55PM  Narrower-than-Expected Loss at Cadence Zacks
09-Apr-13 04:05PM  Furiex Pharmaceuticals Announces First Quarter 2013 Earnings Release and Conference Call Business Wire
09:23AM  FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05-Apr-13 03:58PM  Pipeline Progresses at Shire Zacks
03:12PM  4 Healthcare Stock Stories for Weekend Investment Wellness at Wall St. Cheat Sheet
11:58AM  Setback for Valeant Pharma Zacks
04-Apr-13 05:18PM  Valeant Ups Offer for Obagi Zacks
09:15AM  InPlay: Furiex Pharmaceuticals to receive milestone payment for Priligy launch in France Briefing.com
09:15AM  Furiex Pharmaceuticals to Receive Milestone Payment for Priligy® Launch in France Business Wire
02-Apr-13 05:13PM  Setback for Novartis in India Zacks
05:08PM  ArQule Regains ARQ 092 Rights Zacks
25-Mar-13 05:48PM  FDA Panel Favors Abbott's MitraClip Zacks
11:38AM  Positive Data on Novartis' Gilenya Zacks
22-Mar-13 11:48AM  Novartis' Jetrea Gets EU Approval Zacks
21-Mar-13 01:12PM  Pernix Reports Loss in 4Q Zacks
01:04PM  FURIEX PHARMACEUTICALS, INC. Financials EDGAR Online Financials
11:38AM  Valeant to Buy Obagi Medical Zacks
18-Mar-13 04:53PM  Good News for Cadence Pharma Zacks
12:11AM  FURIEX PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report EDGAR Online
14-Mar-13 01:17PM  Corcept's Loss Narrows in 4Q Zacks
12-Mar-13 02:12PM  Narrower-Than-Expected Loss at CADX in 4Q Zacks
11-Mar-13 05:28PM  Pernix Completes Somaxon Buy Zacks
07-Mar-13 07:27PM  New Star Analyst Rankings for Furiex Pharmaceuticals, Inc. StarMine
12:30PM  Furiex Pharmaceuticals Management Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha
11:38AM  EU Approves Roche's Perjeta Zacks
06-Mar-13 05:21PM  Furiex Pharmaceuticals Earnings: Heres Why Investors are Excited Now at Wall St. Cheat Sheet
04:48PM  FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
04:21PM  InPlay: Furiex Pharmaceuticals beats Q4 ests Briefing.com
04:10PM  Furiex Reports Fourth Quarter and Full Year 2012 Financial Results Business Wire
07:07AM  Q4 2012 Furiex Pharmaceuticals Inc Earnings Release - After Market Close CCBN
05-Mar-13 04:28PM  Good News for Pernix Therapeutics Zacks
01-Mar-13 01:08PM  Valeant Misses 4Q Estimates Zacks
08:38AM  Auxilium Beats on All Fronts Zacks
04:16AM  Best Performing U.S. Stocks YTD Through February at Seeking Alpha
26-Feb-13 09:05AM  Furiex Pharmaceuticals to Present at Cowen & Company 33rd Annual Healthcare Conference Business Wire
25-Feb-13 04:20PM  Furiex announces QIDP, FDA Fast Track designations for avarofloxacin at theflyonthewall.com
04:06PM  InPlay: Furiex Pharmaceuticals receives qualified infectious disease product and fast track designations from the U.S. Food and Drug Administration for Avarofloxacin (JNJ-Q2) Briefing.com
04:05PM  Furiex Receives Qualified Infectious Disease Product and Fast Track Designations from the U.S. Food and Drug Administration for Avarofloxacin (JNJ-Q2) Business Wire
14-Feb-13 04:18PM  OncoGenex' Candidate Progresses Zacks
09:56AM  3 Attractively Valued Biotechs From BIO CEO 2013 at Seeking Alpha
07:41AM  4 Stocks Spiking on Unusual Volume at TheStreet
11-Feb-13 06:38PM  Best-Performing Russell 3000 Stocks Year To Date at Seeking Alpha
08-Feb-13 09:28AM  Wider-Than-Expected Loss at Avanir Zacks
07-Feb-13 04:08PM  Data on Auxilium's Xiaflex Zacks
06-Feb-13 02:46PM  These 10 ¿¿Buy⿝ Rated Stocks Have Significant Insider Buying Activity at TheStreet
04:34AM  January Top 10: Furiex at Motley Fool
03-Feb-13 10:02AM  5 of Last Week's Biggest Winners at Motley Fool
30-Jan-13 03:58PM  Santarus Files Suit against Mylan Zacks
29-Jan-13 06:04PM  Nasdaq stocks posting largest volume increases AP -6.59%
04:09PM  Furiex Pharmaceuticals Announces Fourth Quarter and Full Year 2012 Earnings Release and Conference Call Business Wire
01:18PM  Nasdaq stocks posting largest percentage increases AP
28-Jan-13 08:02PM  Feel the Fury of Furiex at Motley Fool +66.38%
06:08PM  Nasdaq stocks posting largest volume increases AP
06:08PM  Nasdaq stocks posting largest percentage increases AP
04:37PM  Blue Chips Snap Win Streak at The Wall Street Journal
04:18PM  A Look at Three Big-Time Biotech Movers at Motley Fool
04:08PM  Furiex Rises on FDA Approval of Takeda Diabetes Medicine at Bloomberg
03:46PM  Stocks Edge Lower at The Wall Street Journal
03:15PM  Mondays movers: Yahoo slips ahead of Q4 earnings at MarketWatch
02:03PM  Stocks Edge Lower at The Wall Street Journal
01:43PM  Furiex jumps after diabetes drug approval AP
01:26PM  Nasdaq stocks posting largest percentage increases AP
01:11PM  Why Furiex Shares Skyrocketed at Motley Fool
01:11PM  Monday Options Brief: PETM, FURX & SPLS at Seeking Alpha
12:30PM  FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
12:28PM  Caterpillar, Apple Rise in Flat Market at The Wall Street Journal
12:28PM  Mondays movers: Herbalife battered by FTC jitters at MarketWatch
12:15PM  Caterpillar, Apple Rise in Flat Market at The Wall Street Journal
11:44AM  Mondays movers: Facebook liked by Raymond James at MarketWatch
10:38AM  Stocks Fade, Despite Caterpillar at The Wall Street Journal
09:57AM  Caterpillar Leads Dow at The Wall Street Journal
09:52AM  Caterpillar Leads Dow at The Wall Street Journal
09:40AM  Furiex Rises on FDA Approval of Takeda Diabetes Medicine at Bloomberg
09:10AM  FDA decision spells dollars for Morrisville's Furiex at bizjournals.com
09:03AM  Stock Futures Rise After Caterpillar, Durable Goods Reports at TheStreet
09:01AM  Furiex Rises on FDA Approval of Takeda Diabetes Medicine at Bloomberg
08:37AM  BRIEF-Furiex Pharma jumps in premarket after FDA ok's new drug treatments for type 2 diabetes at Reuters
08:35AM  Caterpillar climbs on earnings beat optionMONSTER
08:34AM  Mondays movers: Transocean up on Icahn stake at MarketWatch
04:38AM  Takeda Jumps After Winning FDA Approval for Diabetes Drug at Bloomberg
12:22AM  Coverage initiated on Furiex Pharmaceuticals by Canaccord Genuity Briefing.com
27-Jan-13 11:48PM  Takeda Jumps After Winning FDA Approval for Diabetes Drug at Bloomberg
10:01AM  Takeda Diabetes Drug Succeeding Actos Wins FDA Approval at Bloomberg
25-Jan-13 07:00PM  Furiex Confirms Takedas Receipt of FDA Approval of NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the Treatment of Type 2 Diabetes Business Wire
05:25PM  Takeda Diabetes Drug Succeeding Actos Wins FDA Approval at Bloomberg
27-Nov-12 04:00AM  Furiex Pharmaceuticals Inc. Stock Upgraded (FURX) at TheStreet
10-Nov-12 01:04PM  FURIEX PHARMACEUTICALS, INC. Financials EDGAR Online Financials
06-Nov-12 04:11PM  FURIEX PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
04-Nov-12 09:34AM  New Star Analyst Rankings for Furiex Pharmaceuticals, Inc. StarMine
02-Nov-12 08:12PM  Furiex Pharmaceuticals' CEO Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company's products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.